Why do some of the most deadliest cancers receive comparatively less funding from the NIH?
Cancer research funding from the National Institutes of Health does not proportionally reflect which diseases are most deadly, according to a new study that examined federal investment across nine major tumor types in the United States. The findings raise pointed questions about whether current priorities align with clinical urgency or whether historical patterns and advocacy […]